Literature DB >> 27083148

The regulatory role of interferon-γ producing gamma delta T cells via the suppression of T helper 17 cell activity in bleomycin-induced pulmonary fibrosis.

S Segawa1, D Goto1, A Iizuka1, S Kaneko1, M Yokosawa1, Y Kondo1, I Matsumoto1, T Sumida1.   

Abstract

Interstitial pneumonia (IP) is a chronic progressive interstitial lung disease associated with poor prognosis and high mortality. However, the pathogenesis of IP remains to be elucidated. The aim of this study was to clarify the role of pulmonary γδT cells in IP. In wild-type (WT) mice exposed to bleomycin, pulmonary γδT cells were expanded and produced large amounts of interferon (IFN)-γ and interleukin (IL)-17A. Histological and biochemical analyses showed that bleomycin-induced IP was more severe in T cell receptor (TCR-δ-deficient (TCRδ(-/-) ) mice than WT mice. In TCRδ(-/-) mice, pulmonary IL-17A(+) CD4(+) Τ cells expanded at days 7 and 14 after bleomycin exposure. In TCRδ(-/-) mice infused with γδT cells from WT mice, the number of pulmonary IL-17A(+) CD4(+) T cells was lower than in TCRδ(-/-) mice. The examination of IL-17A(-/-) TCRδ(-/-) mice indicated that γδT cells suppressed pulmonary fibrosis through the suppression of IL-17A(+) CD4(+) T cells. The differentiation of T helper (Th)17 cells was determined in vitro, and CD4(+) cells isolated from TCRδ(-/-) mice showed normal differentiation of Th17 cells compared with WT mice. Th17 cell differentiation was suppressed in the presence of IFN-γ producing γδT cells in vitro. Pulmonary fibrosis was attenuated by IFN-γ-producing γδT cells through the suppression of pulmonary IL-17A(+) CD4(+) T cells. These results suggested that pulmonary γδT cells seem to play a regulatory role in the development of bleomycin-induced IP mouse model via the suppression of IL-17A production.
© 2016 British Society for Immunology.

Entities:  

Keywords:  IL-17A; gamma delta T cell; interferon-γ; interstitial pneumonia

Mesh:

Substances:

Year:  2016        PMID: 27083148      PMCID: PMC4991517          DOI: 10.1111/cei.12802

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

1.  CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells.

Authors:  Jan D Haas; Frano H Malinarich González; Susanne Schmitz; Vijaykumar Chennupati; Lisa Föhse; Elisabeth Kremmer; Reinhold Förster; Immo Prinz
Journal:  Eur J Immunol       Date:  2009-12       Impact factor: 5.532

2.  Expression of B7-1, B7-2, and interleukin 12 in bleomycin-induced pneumopathy in mice.

Authors:  Y Kaneko; K Kuwano; N Hagimoto; H Miyazaki; M Kawasaki; M Fujita; R Kunitake; T Maeyama; N Hara
Journal:  Int Arch Allergy Immunol       Date:  1998-08       Impact factor: 2.749

3.  IL-12 attenuates bleomycin-induced pulmonary fibrosis.

Authors:  M P Keane; J A Belperio; M D Burdick; R M Strieter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

Review 4.  Development and function of interleukin 17-producing γδ T cells.

Authors:  Thomas Korn; Franziska Petermann
Journal:  Ann N Y Acad Sci       Date:  2012-01-12       Impact factor: 5.691

5.  Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis.

Authors:  Toru Kimura; Yukio Ishii; Yuko Morishima; Akira Shibuya; Kazuko Shibuya; Masaru Taniguchi; Mie Mochizuki; Ahmed E Hegab; Tohru Sakamoto; Akihiro Nomura; Kiyohisa Sekizawa
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

6.  Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts.

Authors:  P Gillery; H Serpier; M Polette; G Bellon; C Clavel; Y Wegrowski; P Birembaut; B Kalis; R Cariou; F X Maquart
Journal:  Eur J Cell Biol       Date:  1992-04       Impact factor: 4.492

7.  Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice.

Authors:  Tomoaki Hoshino; Masaki Okamoto; Yuki Sakazaki; Seiya Kato; Howard A Young; Hisamichi Aizawa
Journal:  Am J Respir Cell Mol Biol       Date:  2009-03-05       Impact factor: 6.914

8.  Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.

Authors:  Cong-Qiu Chu; David Swart; Dina Alcorn; Joel Tocker; Keith B Elkon
Journal:  Arthritis Rheum       Date:  2007-04

9.  Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

Authors:  Caroline E Sutton; Stephen J Lalor; Cheryl M Sweeney; Corinna F Brereton; Ed C Lavelle; Kingston H G Mills
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  8 in total

Review 1.  IL-17 in the lung: the good, the bad, and the ugly.

Authors:  Stephen J Gurczynski; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

2.  Th17 cells contribute to pulmonary fibrosis and inflammation during chronic kidney disease progression after acute ischemia.

Authors:  Purvi Mehrotra; Jason A Collett; Susan J Gunst; David P Basile
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-14       Impact factor: 3.619

3.  Deletion of mTORC1 Activity in CD4+ T Cells Is Associated with Lung Fibrosis and Increased γδ T Cells.

Authors:  Christine L Vigeland; Samuel L Collins; Yee Chan-Li; Andrew H Hughes; Min-Hee Oh; Jonathan D Powell; Maureen R Horton
Journal:  PLoS One       Date:  2016-09-20       Impact factor: 3.240

Review 4.  The Roles of Immune Cells in the Pathogenesis of Fibrosis.

Authors:  Enyu Huang; Na Peng; Fan Xiao; Dajun Hu; Xiaohui Wang; Liwei Lu
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

5.  Mechanism of Fei-Xian Formula in the Treatment of Pulmonary Fibrosis on the Basis of Network Pharmacology Analysis Combined with Molecular Docking Validation.

Authors:  Xiao-Li Chen; Cheng Tang; Qing-Ling Xiao; Zhong-Hua Pang; Dan-Dan Zhou; Jin Xu; Qi Wang; Ya-Xi Zhao; Qi-Yong Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-03       Impact factor: 2.629

6.  Two Distinct Mechanisms Underlying γδ T Cell-Mediated Regulation of Collagen Type I in Lung Fibroblasts.

Authors:  Daisuke Okuno; Noriho Sakamoto; Yoshiko Akiyama; Takatomo Tokito; Atsuko Hara; Takashi Kido; Hiroshi Ishimoto; Yuji Ishimatsu; Mohammed S O Tagod; Haruki Okamura; Yoshimasa Tanaka; Hiroshi Mukae
Journal:  Cells       Date:  2022-09-09       Impact factor: 7.666

7.  Association of Decreased Percentage of Vδ2+Vγ9+ γδ T Cells With Disease Severity in Multiple Sclerosis.

Authors:  Guzailiayi Maimaitijiang; Koji Shinoda; Yuri Nakamura; Katsuhisa Masaki; Takuya Matsushita; Noriko Isobe; Ryo Yamasaki; Yasunobu Yoshikai; Jun-Ichi Kira
Journal:  Front Immunol       Date:  2018-04-10       Impact factor: 7.561

Review 8.  T Cells in Fibrosis and Fibrotic Diseases.

Authors:  Mengjuan Zhang; Song Zhang
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.